NCT01603134View on ClinicalTrials.gov

Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Fasting State
Interventions
DRUG

Allopurinol

300 mg tablet once a day

DRUG

Allopurinol

300 mg tablet once a day

Trial Locations (1)

Unknown

Accutest Research Lab (I) Pvt. Ltd., Ahmedabad

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY